Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015672 (
fatigue
)
51,768
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inspiratory muscle
fatigue
(IMF) can develop during exhaustive exercise and cause tachypnea or rapid shallow breathing. We assessed the effects of rib
cage
muscle (RCM-F) and diaphragm
fatigue
(DIA-F) on breathing pattern and respiratory mechanics during high-intensity endurance exercise. Twelve healthy subjects performed a constant-load (85% maximal power) cycling test to exhaustion with prior IMF and a cycling test of similar intensity and duration without prior IMF (control). IMF was induced by resistive breathing and assessed by oesophageal and gastric twitch pressure measurements during cervical magnetic stimulation. Both RCM-F and DIA-F increased RCM and abdominal muscle force production during exercise compared to control. With RCM-F, tidal volume decreased while it increased with DIA-F. RCM-F was associated with a smaller increase in end-expiratory oesophageal pressure (i.e. decrease in lung volume) than DIA-F. These results suggest that RCM-F and not DIA-F is associated with rapid shallow breathing and that lowering the operating lung volume with DIA-F may help to preserve diaphragmatic function.
...
PMID:Influence of diaphragm and rib cage muscle fatigue on breathing during endurance exercise. 1642 67
Cancer-associated malnutrition can result from local effects of a tumour, the host response to the tumour and anticancer therapies. Although cancer patients often have reduced food intake (due to systemic effects of the disease, local tumour effects, psychological effects or adverse effects of treatment), alterations in nutrient metabolism and resting energy expenditure (REE) may also contribute to nutritional status. Several agents produced by the tumour directly, or systemically in response to the tumour, such as pro-inflammatory cytokines and hormones, have been implicated in the pathogenesis of malnutrition and cachexia. The consequences of malnutrition include impairment of immune functions, performance status, muscle function, and quality of life. In addition, responses to chemotherapy are decreased, chemotherapy-induced toxicity and complications are more frequent and severe, and survival times are shortened. Depression,
fatigue
and malaise also significantly impact on patient well-being. In addition, cancer-related malnutrition is associated with significant healthcare-related costs. Nutritional support, addressing the specific needs of this patient group, is required to help improve prognosis, and reduce the consequences of
cancer-associated
nutritional decline.
...
PMID:The causes and consequences of cancer-associated malnutrition. 1643 58
In this report, we present the case of a 64-year-old woman who sustained a Burch-Schneider
cage
fracture. Prior to this event, she underwent repeated acetabular reconstructions, but in the end prosthesis removal was performed as a salvage procedure. We believe that the primary cause of the fracture was metal
fatigue
facilitated by intraoperative re-contouring of the flange, as well as reuse of the
cage
. Based on this case we caution against repetitive or excessive flange bending during implantation of Burch-Schneider cages and do not recommend their reuse.
...
PMID:Burch-Schneider cage fracture: a case report. 1660 72
Brain cytokines, induced by various inflammatory challenges, have been linked to sickness behaviors, including
fatigue
. However, the relationship between brain cytokines and
fatigue
after exercise is not well understood. Delayed recovery of running performance after muscle-damaging downhill running is associated with increased brain IL-1beta concentration compared with uphill running. However, there has been no systematic evaluation of the direct effect of brain IL-1beta on running performance after exercise-induced muscle damage. This study examined the specific role of brain IL-1beta on running performance (either treadmill or wheel running) after uphill and downhill running by manipulating brain IL-1beta activity via intracerebroventricular injection of either IL-1 receptor antagonist (ra; downhill runners) or IL-1beta (uphill runners). Male C57BL/6 mice were assigned to the following groups: uphill-saline, uphill-IL-1beta, downhill-saline, or downhill-IL-1ra. Mice initially ran on a motor-driven treadmill at 22 m/min and -14% or +14% grade for 150 min. After the run, at 8 h (wheel
cage
) or 22 h (treadmill), uphill mice received intracerebroventricular injections of IL-1beta (900 pg in 2 microl saline) or saline (2 microl), whereas downhill runners received IL-1ra (1.8 microg in 2 microl saline) or saline (2 microl). Later (2 h), running performance was measured (wheel running activity and treadmill run to
fatigue
). Injection of IL-1beta significantly decreased wheel running activity in uphill runners (P<0.01), whereas IL-1ra improved wheel running in downhill runners (P<0.05). Similarly, IL-1beta decreased and Il-1ra increased run time to
fatigue
in the uphill and downhill runners, respectively (P<0.01). These results support the hypothesis that increased brain IL-1beta plays an important role in
fatigue
after muscle-damaging exercise.
...
PMID:Role of brain IL-1beta on fatigue after exercise-induced muscle damage. 1677 69
Implants of carbon fiber composite have been widely used in orthopedic and spinal surgeries. However, studies using carbon fiber-reinforced cages demonstrate frequent appearance of fibrous layer interposed between the implant and the surrounding bone. The aim of the present study was to test the possibility of coating a biocompatible metal layer on top of the carbon fiber material, to improve its biological performance. Tantalum was chosen because of its bone compatibility, based on our previous studies. A novel spinal fusion
cage
was fabricated by applying a thin tantalum coating on the surface of carbon-carbon composite material through chemical vapor deposition. Mechanical and biological performance was tested in vitro and in vivo. Compress strength was found to be 4.9 kN (SD, 0.2).
Fatigue
test with 500,000 cycles was passed. In vitro radiological evaluation demonstrated good compatibility with X-ray and CT scan examinations. In vivo test employed eight pigs weighing 50 kg each. Instrumented lumbar spine fusion of L3/4 and L4/5 with these cages was performed on each pig. After 3 months, excellent bone integration property was demonstrated by direct contact of the
cage
with the host bone and newly formed bone. No inflammatory cells were found around the implant. Cages packed with two different graft materials (autograft and COLLOSS) achieved the same new bone formation. The present study proved that coating tantalum on top of the carbon-based implant is feasible, and good bone integration could be achieved.
...
PMID:Experimental lumbar spine fusion with novel tantalum-coated carbon fiber implant. 1692 10
Fatigue
can be defined physiologically as inability to maintain the expected power output. At present, no standard of
fatigue
are yet available. In order to find biomarkers of
fatigue
, we investigated the level of delta-aminolevulinic acid (ALA), the first intermediate metabolite in the heme biosynthetic pathway, in the plasma and urine of an animal model of
fatigue
. To prepare fatigued animals, we kept rats for 5 days in a
cage
filled with water to a height of 1.5 cm. As a result, the plasma and urinary ALA levels were increased in the fatigued animals as compared with those in the control animals. One day after the rats had been returned to their normal cages, these increased levels were restored to the control ones. We also examined the activity of the enzyme ALA dehydratase (ALAD), which is the second enzyme in the heme biosynthetic pathway, and ALAD gene expression during the
fatigue
and its recovery sessions. The ALAD activity, as well as its gene expression, in the liver of the fatigued animals was decreased as compared with those of the control animals. Both activity and gene expression of ALAD were recovered to their respective control levels after the rats had been allowed to rest in their normal cages for 1 day. Furthermore, the activity of ALA synthase (ALAS), the rate-limiting enzyme in the heme biosynthesis, in the liver was increased after the
fatigue
session for 5 days. Although this level of increase in the plasma concentration of ALA may not induce
fatigue
, increase in plasma and urinary ALA levels can be biomarkers of
fatigue
.
...
PMID:Decrease of hepatic delta-aminolevulinate dehydratase activity in an animal model of fatigue. 1720 41
Managing severe acetabular bone loss in total hip arthroplasty revision can be a tremendous challenge. Osteolysis and migration of the acetabular component can lead to large uncontained defects. Traditionally, these deficiencies have been treated with allograft with or without the support of a
cage
. In severe cases, a majority of the
cage
support is via allograft instead of host bone. Sometimes, with remodeling and resorption of the allograft, the
cage
can lose structural support, leading to
fatigue
and failure. In these situations, trabecular metal has become a viable alternative. Deficiencies of acetabular bone can be independently addressed and reconstructed providing initial stability and, we believe, long-term biologic fixation to host bone.
...
PMID:Addressing severe bone deficiency: what a cage will not do. 1757 Feb 91
Fatigue
is a common and highly distressing symptom of
cancer associated
with reduced quality of life and considerable psychological and functional morbidity. The reported prevalence of cancer-related
fatigue
ranges from 4% to 91%, depending on the specific cancer population studied and the methods of assessment. Cancer-related
fatigue
has typically been underreported, underdiagnosed, and undertreated.
Fatigue
and depression may coexist in cancer patients, and considerable overlap of symptoms occurs. This is partly the reason for the interest in examining the role of psychotropic medications in treating
fatigue
. Clarifying the relationship between depression and
fatigue
is necessary to effectively evaluate and treat cancer-related
fatigue
. Even with International Classification of Diseases criteria, differentiating cancer-related
fatigue
is difficult. Psychotropic drugs that have been studied for cancer-related
fatigue
include psychostimulants, wakefulness-promoting agents, and antidepressants. Methylphenidate has been studied most and seems to be effective and well tolerated despite common side effects. Some preliminary data support using modafinil in cancer-related
fatigue
with less concern about tolerance or dependence. Antidepressant studies have shown mixed results. Paroxetine seems to show benefit for
fatigue
primarily when it is a symptom of clinical depression. Bupropion, a norepinephrine/dopamine reuptake inhibitor, may have psychostimulant-like effects, and therefore may be more beneficial for treating
fatigue
. However, studies are currently limited. Randomized, placebo-controlled trials with specific agents are needed to further assess the efficacy and tolerability of psychotropic medications in the treatment of cancer-related
fatigue
.
...
PMID:Update on psychotropic medications for cancer-related fatigue. 1805 30
Limited opportunity for movement and load-bearing exercise for conventionally caged laying hens leads to bone loss and increased susceptibility to osteoporosis, bone fractures, and
cage
layer
fatigue
, all of which compromise hen welfare and have negative consequences for production. The objective of this study was to compare bone mineral density (BMD) and strength measures of White Leghorns housed in conventional battery cages (CONV), cages modified to incorporate a nest box and perch (MOD), and commercially available, furnished colony cages with (CWDB) or without (CWODB) a raised dust bath. Hens reared on floor litter were randomly allocated to 1 of 4
cage
systems at 19 wk of age. Hen-day production and egg quality were measured between 20 and 64 wk. At 65 wk, hens were killed, and right femur, tibia, and humerus were excised. Bone mineral density was assessed using quantitative computed tomography, and breaking strength was measured with an Instron Materials Tester. In the femur and tibia, CONV hens exhibited lower total BMD, bone mass, cortical bone area, cortical bone mass, and bone-breaking strength than CWDB, CWODB, and MOD hens. Density and cross-sectional area of bone in the trabecular space was highest in CONV. In the humerus, total and cortical BMD and mass and breaking strength values were higher for colony-housed birds than hens in CONV and MOD. The MOD birds did not exhibit increased humeral BMD or strength measures over CONV hens. These findings provide evidence that hens housed in modified and colony cages, furnished systems that promote load-bearing movement, are better able to preserve cortical structural bone than conventionally caged hens and simultaneously have stronger bones. Furthermore, inclusion of raised amenities that encourage wing loading is necessary to reduce humeral cortical bone loss. The overall absence of correlation between egg production or quality and bone quality measures also suggests that improved bone quality in CWDB, CWODB, and MOD furnished cages is not the result of lowered egg production or quality.
...
PMID:Bone mineral density and breaking strength of White Leghorns housed in conventional, modified, and commercially available colony battery cages. 1842 Sep 72
PURPOSE The experience of patients with cancer often involves symptoms of
fatigue
, anorexia, depression, and dyspnea. METHODS We developed a set of standards through an iterative process of structured literature review and development and refinement of topic areas and standards and subjected recommendations to rating by a multidisciplinary expert panel. Results For
fatigue
, providers should screen patients at the initial visit, for newly identified advanced cancer, and at chemotherapy visits; assess for depression and insomnia in newly identified
fatigue
; and follow up after treatment for
fatigue
or a secondary cause. For anorexia, providers should screen at the initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer, evaluate for associated symptoms, treat underlying causes, provide nutritional counseling for patients undergoing treatment that may affect nutritional intake, and follow up patients given appetite stimulants. For depression, providers should screen newly diagnosed patients, those started on chemotherapy or radiotherapy, those with newly identified advanced disease, and those expressing a desire for hastened death; document a treatment plan in diagnosed patients; and follow up response after treatment. For general dyspnea, providers should evaluate for causes of new or worsening dyspnea, treat or symptomatically manage underlying causes, follow up to evaluate treatment effectiveness, and offer opioids in advanced cancer when other treatments are unsuccessful. For dyspnea and malignant pleural effusions, providers should offer thoracentesis, follow up after thoracentesis, and offer pleurodesis or a drainage procedure for patients with reaccumulation and dyspnea. CONCLUSION These standards provide a framework for evidence-based screening, assessment, treatment, and follow-up for
cancer-associated
symptoms.
...
PMID:Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. 1868 57
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>